Literature DB >> 26869331

[In Germany too many ICD implantations are performed: pro].

D Böcker1.   

Abstract

Implantable cardioverter defibrillators (ICD) have undoubtedly developed into one of the most successful therapies in the field of cardiology over the last decades; however, a significant number of ICD operations are carried out in patients who do not benefit from ICD therapy despite significant left ventricular dysfunction. These patients can easily be identified. An ICD therapy does not prolong life in the setting of significant chronic kidney disease. In elderly patients the benefit of prophylactic ICD therapy is very small. Simple risk scores can identify other patients who do not benefit from this treatment. The number of ICD operations can also be significantly reduced by the use of devices with an extended longevity.

Entities:  

Keywords:  Implantable defibrillators; Left ventricular dysfunction; Prevention; Renal insufficiency; Sudden cardiac death

Mesh:

Year:  2016        PMID: 26869331     DOI: 10.1007/s00059-016-4404-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  14 in total

1.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

2.  Non-evidence-based ICD implantations in the United States.

Authors:  Sana M Al-Khatib; Anne Hellkamp; Jeptha Curtis; Daniel Mark; Eric Peterson; Gillian D Sanders; Paul A Heidenreich; Adrian F Hernandez; Lesley H Curtis; Stephen Hammill
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

3.  Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.

Authors:  Patrick H Pun; Anne S Hellkamp; Gillian D Sanders; John P Middleton; Stephen C Hammill; Hussein R Al-Khalidi; Lesley H Curtis; Gregg C Fonarow; Sana M Al-Khatib
Journal:  Nephrol Dial Transplant       Date:  2014-11-17       Impact factor: 5.992

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.

Authors:  Kristina Wasmer; Julia Köbe; Dietrich Andresen; Ralf Zahn; Stefan G Spitzer; Joachim Jehle; Johannes Brachmann; Christoph Stellbrink; Eimo Martens; Matthias Hochadel; Jochen Senges; Helmut Klein; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2013-03-30       Impact factor: 5.460

6.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

Authors:  Scott D Solomon; Steve Zelenkofske; John J V McMurray; Peter V Finn; Eric Velazquez; George Ertl; Adam Harsanyi; Jean L Rouleau; Aldo Maggioni; Lars Kober; Harvey White; Frans Van de Werf; Karen Pieper; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

7.  Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.

Authors:  Alon Barsheshet; Arthur J Moss; David T Huang; Scott McNitt; Wojciech Zareba; Ilan Goldenberg
Journal:  J Am Coll Cardiol       Date:  2012-06-05       Impact factor: 24.094

8.  Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.

Authors:  Jeffrey S Healey; Al P Hallstrom; Karl-Heinz Kuck; Girish Nair; Eleanor P Schron; Robin S Roberts; Carlos A Morillo; Stuart J Connolly
Journal:  Eur Heart J       Date:  2007-02-05       Impact factor: 29.983

9.  Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.

Authors:  Dietmar Bänsch; Hendrik Bonnemeier; Johan Brandt; Frank Bode; Jesper Hastrup Svendsen; Miloš Táborský; Stefan Kuster; Carina Blomström-Lundqvist; Angelika Felk; Tino Hauser; Anna Suling; Karl Wegscheider
Journal:  Eur Heart J       Date:  2015-06-25       Impact factor: 29.983

10.  Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.

Authors:  Chih-Ying Chen; Lynne Warner Stevenson; Garrick C Stewart; Deepak L Bhatt; Manisha Desai; John D Seeger; Lauren Williams; Jessica J Jalbert; Soko Setoguchi
Journal:  BMJ       Date:  2015-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.